All Posts
AMMF, Cholangiocarcinoma Foundation, TargetCancer Foundation, and The Bili Project, Award Unique Collaborative Grant
Read the full article by clicking here.
Debora Mae (Lankford) Waite
Debora Mae (Lankford) Waite age 49, passed away peacefully in her home surrounded by family on August 31, 2019 after…
Justin S. Lee
5/1/1950 – 9/2/2019 On September 2, 2019, we lost our beloved father and husband to cholangiocarcinoma (bile duct) cancer after…
University of Chicago Regional Symposium
Join us for an afternoon dedicated to the science of cholangiocarcinoma. The symposium will include presentations from the University of…
A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma
Study Name A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients with Cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable)…
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
Study Name Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer ClinicalTrials.gov…
Webinar: CCF & Ciitizen-Take Control of Your Health Data
On August 12, the Cholangiocarcinoma Foundation announced a partnership with Ciitizen. This partnership is formed around the belief that you…
PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Study Name PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations…
Michelle's Hot Peeps Beat CC
Over 150 runners braved the Texas heat in Taylor, TX, on Saturday, Aug. 10th, to support the second annual “Michelle’s…
Repurposing Drugs for Cholangiocarcinoma
Over three years ago I was diagnosed with an incurable cancer, at the age of just 39 when my 3…